Terms ending in 2036
Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,232,111 | Pump, Motor and Assembly for Beneficial Agent Delivery In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 10,213,546 | Devices and Methods for Delivering a Beneficial Agent to a User In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 10,238,677 | Treatment of Filarial Diseases In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 10,117,843 | Levodopa and Carbidopa Intestinal Gel and Methods of Use In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 10,744,068 | Cylindrical Pill Dispenser and Related Methods of Use In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 10,421,759 | Fused Bicyclic Compounds for the Treatment of Disease In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 10,744,069 | Systems and Methods for Tubing Delivery In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 9,856,253 | Tricyclic Modulators of TNF Signaling In force · High confidence | AbbVie, Inc. | In force | High confidence | |
| US 9,879,016 | Indazolones as Modulators of TNF Signaling In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 10,160,748 | Indazolones as Modulators of TNF Signaling In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | |
| 69 more term ends in 2036 · Pro | |||||
10 of 79 patents shown. Soonest term end first, then patent number.
Pro members see all 79.
77 of these are in force and held by AbbVie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.